Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Kite Pharma Inc (NASDAQ:KITE)

82.64
Delayed Data
As of 3:59pm ET
 -0.16 / -0.19%
Today’s Change
39.82
Today|||52-Week Range
88.58
+84.30%
Year-to-Date

Today’s Trading

Previous close82.80
Today’s open82.80
Day’s range81.96 - 83.34
Volume474,723
Average volume (3 months)1,360,616
Market cap$4.5B
Dividend yield--
Data as of 3:59pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)-134.33%
Earnings growth (this year)-50.16%
Earnings growth (next 5 years)--
Revenue growth (last year)+28.46%
P/E ratioNM
Price/Sales98.98
Price/Book9.69

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...+0.31+0.58%
TECHBio-Techne Corp+0.86+0.81%
BLUEbluebird bio Inc+0.40+0.45%
NKTRNektar Therapeutics+0.14+0.75%
Data as of 3:59pm ET, 04/27/2017

Financials

Next reporting dateMay 19, 2017
EPS forecast (this quarter)-$1.64
Annual revenue (last year)$22.2M
Annual profit (last year)-$267.1M
Net profit margin-1,204.65%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Arie S. Belldegrun
Chief Operating Officer
Cynthia M. Butitta
Corporate headquarters
Santa Monica, California

Forecasts